• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锂、多尿与精神病患者异常的日间体重增加

Lithium, polyuria and abnormal diurnal weight gain in psychosis.

作者信息

Vieweg W V, Godleski L S, Hundley P L, Yank G R

机构信息

Western State Hospital, Department of Mental Health and Mental Retardation, Virginia.

出版信息

Acta Psychiatr Scand. 1988 Oct;78(4):510-4. doi: 10.1111/j.1600-0447.1988.tb06375.x.

DOI:10.1111/j.1600-0447.1988.tb06375.x
PMID:3227972
Abstract

We evaluated diurnal weight gain and polyuria among 31 institutionalized chronically psychotic patients receiving lithium and 42 controls not receiving this drug. The patients were weighed weekly for three weeks at 7 a.m. and 4 p.m. We normalized the diurnal weight gain (NDWG) as a percentage by subtracting the 7 a.m. weight from the 4 p.m. weight, multiplying the difference by 100, and then dividing the result by the 7 a.m. weight. Polyuria was assessed using mean urine creatinine concentration (MUCR). NDWG was abnormal among study patients (1.9 +/- 1.2%) and controls (1.6 +/- 1.5%) independent of lithium treatment. The variation in MUCR explained about 20% of the variation in NDWG in both groups.

摘要

我们评估了31名接受锂盐治疗的住院慢性精神病患者和42名未接受该药物治疗的对照者的日间体重增加和多尿情况。在三周内,每周上午7点和下午4点对患者进行称重。我们通过用下午4点的体重减去上午7点的体重,将差值乘以100,然后将结果除以上午7点的体重,将日间体重增加(NDWG)标准化为百分比。使用平均尿肌酐浓度(MUCR)评估多尿情况。无论是否接受锂盐治疗,研究患者(1.9 +/- 1.2%)和对照者(1.6 +/- 1.5%)的NDWG均异常。两组中MUCR的变化解释了NDWG变化的约20%。

相似文献

1
Lithium, polyuria and abnormal diurnal weight gain in psychosis.锂、多尿与精神病患者异常的日间体重增加
Acta Psychiatr Scand. 1988 Oct;78(4):510-4. doi: 10.1111/j.1600-0447.1988.tb06375.x.
2
Antipsychotic drugs, lithium, carbamazepine, and abnormal diurnal weight gain in psychosis.抗精神病药物、锂盐、卡马西平与精神病患者日间体重异常增加
Neuropsychopharmacology. 1989 Mar;2(1):39-43. doi: 10.1016/0893-133x(89)90005-5.
3
Diurnal weight gain in chronic psychosis.慢性精神病患者的日间体重增加
Schizophr Bull. 1989;15(3):501-6. doi: 10.1093/schbul/15.3.501.
4
Abnormal diurnal weight gain among chronically psychotic patients contrasted with acutely psychotic patients and normals.慢性精神病患者的日间体重异常增加与急性精神病患者及正常人形成对比。
Psychol Med. 1989 Feb;19(1):105-9. doi: 10.1017/s0033291700011065.
5
Normalization of abnormal diurnal weight gain among chronically psychotic geriatric patients. Is abnormal diurnal weight gain a risk factor in chronic psychosis?慢性精神病老年患者日间体重异常增加的正常化。日间体重异常增加是慢性精神病的危险因素吗?
J Nerv Ment Dis. 1989 Sep;177(9):542-5. doi: 10.1097/00005053-198909000-00004.
6
Survey of diurnal weight gain and urine volume in chronic schizophrenia.慢性精神分裂症患者日间体重增加及尿量的调查
Can J Psychiatry. 1989 Nov;34(8):779-84. doi: 10.1177/070674378903400807.
7
Abnormal diurnal weight gain in chronic psychosis without seasonal change.慢性精神病患者日间体重异常增加,无季节性变化。
Neuropsychobiology. 1988;19(4):176-9. doi: 10.1159/000118456.
8
Failure of antipsychotic drug dose to explain abnormal diurnal weight gain among 129 chronically psychotic inpatients.抗精神病药物剂量无法解释129名慢性精神病住院患者的异常日间体重增加情况。
Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(5):709-23. doi: 10.1016/0278-5846(89)90059-6.
9
The link between fluid intake and weight gain in psychosis.精神病患者液体摄入量与体重增加之间的联系。
Psychosomatics. 1991 Winter;32(1):52-7. doi: 10.1016/s0033-3182(91)72111-7.
10
Abnormal diurnal weight gain among institutionalized patients with manic-depressive spectrum disorders.患有躁郁症谱系障碍的住院患者的异常日间体重增加。
Psychiatr Med. 1990;8(4):129-34.

引用本文的文献

1
Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia".日本神经精神药理学学会:《精神分裂症药物治疗指南》
Neuropsychopharmacol Rep. 2021 Sep;41(3):266-324. doi: 10.1002/npr2.12193. Epub 2021 Aug 12.
2
Polydipsia-hyponatraemia syndrome : epidemiology, clinical features and treatment.多饮-低钠血症综合征:流行病学、临床特征和治疗。
CNS Drugs. 1997 Feb;7(2):121-38. doi: 10.2165/00023210-199707020-00004.